18 hours ago
1
Richard Drury
- Lexeo Therapeutics (NASDAQ:LXEO) has secured approximately $80M through a private placement with institutional and healthcare-focused investors.
- As part of the deal, Lexeo will sell 20.8M shares of common stock or pre-funded warrants for 7M shares.
- Each share comes with a
English (US) ·